Institut Coeur Poumon - CHRU de Lille ( Site 0252)

Lille, Hauts-de-France 59037

0 studies enrolling now · 1 studies all time

What they study most

Hypertension, Pulmonary, Pulmonary Arterial Hypertension

Studies at this site

• A Study of the Efficacy and Safety of Frespaciguat (MK-5475) in Participants With Pulmonary Arterial Hypertension (INSIGNIA-PAH: Phase 2/3 Study of an Inhaled sGC Stimulator in PAH) (MK-5475-007) — Completed